Media & reagents
GMP manufactured products designed for cell and gene therapy to support your transition from discovery through clinical and commercial manufacturing.
As you scale your cell and gene therapies beyond research, products designed to enable clinical and commercial manufacturing are essential to your success.
The Gibco CTS portfolio of cell and gene therapy products are GMP manufactured, safety tested and backed by regulatory documentation to support your transition from discovery through clinical and commercial manufacturing. Through our CTS solutions, we are committed to helping customers streamline therapeutic development, minimize risk, and ease the burden on their quality systems.
Safety testing with accompanying traceability documentation
- Extensive qualification and testing of critical raw materials
- Final product testing (e.g., mycoplasma, endotoxin, sterility)
- Types of traceability documentation: COO, COA, SDS
Dedicated regulatory and quality teams provide product support for customer filings
- Types of specialized documentation include: DMF, RSF, validation, regulatory agency letters
- Products used in over 200 clinical trials and commercialized therapies
- Global CGT regulatory affairs teams with regional expertise
GMP manufactured products designed for CGT manufacturing
- Designed to meet latest guidance for ancillary materials for CGT (USP 1043*, ISO 20399, EP 5.2.12.*)
- Products manufactured under global quality standards (QMS ISO 9001 or 13485)
- 30 years of GMP-compliant manufacturing
Cell therapy instrumentation
Cell therapy instruments, supporting consumables and software products enable CGMP compliant, closed system manufacturing and allow for physical and digital integration.
Viral vector systems
Cost-effective, scalable solutions designed to transition your gene therapy workflow from discovery to commercial manufacturing.
Cell and gene therapy applications
Whether you're developing an induced pluripotent stem cell therapy, specialized immunotherapy, or a gene therapy, our Gibco CTS portfolio offers cell-type and viral vector specific applications that can be leveraged to advance your research to the clinic and beyond.
T Cell Therapy
Specialized Cell Therapy Systems products to isolate, activate, expand, and genetically modify T cells, dendritic cells, or other immune cell types.
Natural Killer (NK) Cell Therapy
Explore cell therapy systems products for expansion, processing, and gene editing of human natural killer (hNK) cells for cell therapy development.
Induced Pluripotent Stem Cell Therapy
Learn more about our solutions across the pluripotent stem cell workflow, from reprogramming to culture.
Neural Stem Cell (NSC) Therapy
Specialized cell therapy products for stem cell– and tissue-derived neural cell cultures.
Viral vector systems
We offer complete, optimized systems for scalable, cost-effective adeno-associated virus (AAV) and lentivirus (LV) vector production.
Cell Therapy Systems support
Providing quality for our customers drives everything we do. In addition to our comprehensive CTS portfolio of products, we offer regulatory documentation to support your transition from research through to commercialization. Experienced cell and gene therapy professionals, technical support teams, and highly specialized scientific teams are available to answer your questions, provide detailed product and protocol consultation, as well as customization services.
CTS AAV-MAX Helper Free AAV Production System
The Gibco CTS AAV-MAX Helper Free AAV Production System enables a smooth transition from discovery through manufacturing, offering one optimized, scalable platform with CGMP manufactured reagent options.
Learn more
Gibco CTS NK-Xpander Medium
Gibco CTS NK-Xpander Medium is designed to proliferate a high yield of functional human NK cells to address the needs of translational and clinical cell therapy researchers with or without the use of feeder cells.
Learn more
Gibco CTS DynaCellect Magnetic Separation System
The CTS DynaCellect Magnetic Separation System is a closed, automated isolation, activation, and bead removal system for cell therapy development and manufacturing.
Learn more
Going green: Enabling sustainability in our CTS products
Sustainable solutions
We are committed to delivering products that serve the research needs of our customers, while striving to develop them in a way that minimizes our use of natural resources and our impact on the environment.
Responsibly packaged
Packaging must protect the product inside—but that doesn’t have to mean sacrificing sustainability. GlutaMAX-I Media Supplement ships at ambient temperature. By “going ambient” for the GlutaMAX Supplement, we help divert an annual total of nearly 2,000 kg (2,700 ft3) of EPS from landfills and incinerators, and reduce the total carbon footprint by over 100 tons annually.
기본 세포 치료 연구에서 임상으로 이행할 때 처음부터 제대로 시작하기 위해서는 고품질 제품과 적절한 문서 준비가 필수적입니다. Cell Therapy System(CTS™) 제품은 연구에서 오염 및 변동성 위험을 최소화하고 규제 검토에 필요한 모든 문서를 제공하므로 실험실 연구에서 임상으로 이행할 때 선택하기에 이상적인 제품입니다.
Cell Therapy System(CTS™) 제품 선택시 어떤 점을 기대할 수 있나요?
관련 문서
- 고객의 품질 시스템에 대한 부담 완화
- 규제 관련 문서 제출 절차를 간소화하고 절차 전반의 위험 감소
- 제품 검색과 평가에 소요되는 시간 절약
무혈청 제형
- 변동성과 오염 위험 최소화
- 로트 간 일관성 가능
- 동일한 프로토콜을 준수하고 실험실 연구부터 임상 연구까지 비교 가능한 결과 확보
전문가 상담
- 50년 넘게 축적된 Gibco® 배지 경험을 바탕
- 모든 제품에 대한 지역별 기술 지원 제공
- 노련한 전문가가 직접 규제 관련 절차 안내
추천 세포 치료 어플리케이션
줄기세포 치료 연구
세포의 분리, 확장, 분화, 특성 분석에 유용한 도구
세포 치료용 신경 배지 및 시약
줄기세포 및 조직 유래 신경 세포 배양에 사용할 수 있는 특수 배지 및 보충제
조직 공학
중간엽 줄기세포 치료 연구를 위한 맞춤 솔루션
A Gibco CTS Mini-Documentary Series
- Opportunities in Cell Therapy Translational Research
- Challenges in Cell Therapy Translational Research
- Impact of Raw Materials on Cell Therapy Development
- Improving Cell Therapy Systems with Raw Material Selection
- Importance of Scalable Cell Therapy Manufacturing Processes
- Benefits of Documentation in Cell Therapy Development
- Choosing the Ideal Cell Therapy Product Supplier
Videos
세포, 유전자, 조직 기반 제품의 제조나 연구용.특정 제품에 추가 용도 제한이 적용될 수 있습니다.
* 휴먼 ex vivo 조직 및 세포 배양 처리 어플리케이션용.주의:사람이나 동물에게 직접 투여할 수 없습니다.
Stylesheet for Classic Wide Template adjustments